TY - JOUR
T1 - 3D dosimetry for brachytherapy and heterogeneities
AU - Ibbott, G. S.
AU - Heard, M. P.
PY - 2010
Y1 - 2010
N2 - Clinical applications of 3D dosimeters have been considered since the 1950s, when uses of gel dosimeters were first explored [1,2]. Since then, however, the number of investigators has increased, and the body of knowledge regarding gel dosimetry has grown considerably [3-5]. 3D dosimetry is essential for a number of clinical applications, including the complete characterisation of brachytherapy sources, and the evaluation of dose distributions around and within inhomogeneous tissues. However, each of these conditions presents several challenges which must be overcome to allow the accurate and practical determination of dose distributions.
AB - Clinical applications of 3D dosimeters have been considered since the 1950s, when uses of gel dosimeters were first explored [1,2]. Since then, however, the number of investigators has increased, and the body of knowledge regarding gel dosimetry has grown considerably [3-5]. 3D dosimetry is essential for a number of clinical applications, including the complete characterisation of brachytherapy sources, and the evaluation of dose distributions around and within inhomogeneous tissues. However, each of these conditions presents several challenges which must be overcome to allow the accurate and practical determination of dose distributions.
UR - http://www.scopus.com/inward/record.url?scp=78650548786&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=78650548786&partnerID=8YFLogxK
U2 - 10.1088/1742-6596/250/1/012088
DO - 10.1088/1742-6596/250/1/012088
M3 - Article
AN - SCOPUS:78650548786
SN - 1742-6588
VL - 250
SP - 436
EP - 441
JO - Journal of Physics: Conference Series
JF - Journal of Physics: Conference Series
M1 - 012088
ER -